Zunsemetinib
Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
Product Specifications
CAS Number
1640282-42-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
513.92
Molecular Formula
C25H22ClF2N5O3
Notes
Research use only, not for human use.
Receptor
MAPK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
039393-ML750 100 µL
OR4F16, NT (OR4F3, Olfactory receptor 4F3/4F16/4F29, Olfactory receptor OR1-1) (MaxLight 750) discontinued
Ask
View Details MBS7030488-01 0.02 mg
Recombinant Erwinia amylovora Glucitol/sorbitol-specific phosphotransferase enzyme IIB component (srlE)
Ask
View Details 
MBS7030488-02 0.1 mg
Recombinant Erwinia amylovora Glucitol/sorbitol-specific phosphotransferase enzyme IIB component (srlE)
Ask
View Details 
MBS7030488-03 5x 0.1 mg
Recombinant Erwinia amylovora Glucitol/sorbitol-specific phosphotransferase enzyme IIB component (srlE)
Ask
View Details 